Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/17/2007CN100342858C Application of yam total saponin in the process for preparing anti-aspirin resisting medicine
10/17/2007CN100342857C Ginseng pearl drpo pills and preparation process thereof
10/17/2007CN100342856C Composition of danazol semisolid skeleton preparation
10/17/2007CN100342855C Activating element for preventing baldness
10/17/2007CN100342854C Cefadole oral liquor antibacterial composition
10/17/2007CN100342853C Therapeutic treatment
10/17/2007CN100342852C Dispersive glimepiride tablet and its prepn process
10/17/2007CN100342851C Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
10/17/2007CN100342850C Novel use of formaldehyde in preparation of drug for animals
10/17/2007CN100342796C Food product and process for manufacturing same
10/17/2007CN100342785C Synergistic mixtures of 1,2-alkane diols
10/16/2007USRE39888 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
10/16/2007USRE39887 A cyclic depsipeptide from a tunicate of the Ascidiacea class; viricides, antitumor agents, immunosuppressants and cytotoxic agents
10/16/2007US7282599 Administering dithiocarbamate compound having the structural formula R1R2NCS2H for therapy of infection by an RNA virus which attacks the respiratory tract and causes disease selected from picornavirus, ortho-myxovirus, rhinovirus, enterovirus, coxsackie virus, aphthovirus, or paramyxovirus
10/16/2007US7282593 Withanamide and withanolide compositions and method of use thereof
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/16/2007US7282590 Drug conjugates
10/16/2007US7282585 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline
10/16/2007US7282582 Combining 1-monoacyldipyrromethane with a boron compound to produce a metal complex
10/16/2007US7282523 Pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease
10/16/2007US7282522 Anti-aging skin care; e.g. N-[4-(N-hydroxycarbamoyl)phenyl]benzamide; inhibits collagenase and/or elastase expression; less skin irritation than conventional retinoic acid
10/16/2007US7282521 Treating HIV-1
10/16/2007US7282520 Gallic acid glycoside used in a preparation for external use that is applicable as a hair cosmetic
10/16/2007US7282519 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
10/16/2007US7282518 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/16/2007US7282517 Method of manufacturing glimepiride and the respective intermediate
10/16/2007US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders
10/16/2007US7282515 Using 1,3-diazaspiro( 4.5)decane-2,4-(dione or dithione)
10/16/2007US7282514 Reactive probes for two-photon fluorescent imaging and sensing
10/16/2007US7282513 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007US7282511 Isatine derivatives with neurotrophic activity
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/16/2007US7282509 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
10/16/2007US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists
10/16/2007US7282507 Indole derivatives as selective androgen receptor modulators (SARMS)
10/16/2007US7282506 2,8-disubstituted naphthyridine derivatives
10/16/2007US7282505 Dissolving amorphous rapamycin in t-butyl methyl ether and recrystallizing rapamycin to form rapamycin form II; anticarcinogenic, antitumor, immunosuppressant, antiproliferative, antigunal agent
10/16/2007US7282504 Kinase inhibitors
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders
10/16/2007US7282499 4,5,6,7-tetrahydro-4-(2-(morpholin-4-yl)ethyl)-1-phenyl-1H-indazole oxalate; N-benzyl-2-(1-(4-fluorophenyl)-4,5,6,7-tetrahydro-1H-indazol-4-yl)-N-methyl-ethanamine; therapeutical, prophylaxis, psychosis or pain
10/16/2007US7282498 Substituted fused pyrroleoximes and fused pyrazoleoximes
10/16/2007US7282497 Synergistic mixtures of 6-Chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide and 4-chloro-N-{1-[1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}-1-benzothiophene-2-sulfonamide; improved oral bioavailability and pharmacokinetics
10/16/2007US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents
10/16/2007US7282495 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
10/16/2007US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/16/2007US7282493 Analogs of benzoquinone-containing ansamycins and methods of use thereof
10/16/2007US7282491 inhibiting proteasomal activity in a pathogen under conditions effective to make the pathogen susceptible to antibacterial host defenses, thereby treating the pathogen infection
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia
10/16/2007US7282487 Method for treating bacterial infections in horses or pigs with tilmicosin
10/16/2007US7282486 A dosage form of pure crystalline azithromycin monohydrate hemi-ethanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds and fish; drug resistance
10/16/2007US7282485 Heating salts of 1,2-O-isopropylidene-D-glucuronic acid in water-containing solution in presence of an acid agent (sulphonic acid cation exchanger resins)
10/16/2007US7282484 Oral administration of an amino acid with a N-terminal blocking group and a N-(2-boric pyrrolyl) group attached to the carboxyl group; anticarcinogenic, antiproliferative, antimetastasis agents for lung, kidney, pancreatic, breast, and colorectal cancers; angiogenesis inhibition
10/16/2007US7282481 Improved thermostability, acid resistance, alkali resistance, resistance to proteolytic enzymes, and DNA synthesis promoting activity
10/16/2007US7282470 Neutralizes the adverse health effects of both chemical and biological compounds, especially chemical and biological warfare agents, and toxic industrial chemicals; includes solubilizers and oxididative detoxifiers
10/16/2007US7282340 Methods for identifying an analog that promotes nerve regeneration
10/16/2007US7282325 Method of preparing pharmaceutical compositions
10/16/2007US7282223 Kit for cleaning the digestive tract e.g. prior to colonoscopy or surgical procedure; provides calories for daily routine while minimizing stool formation
10/16/2007CA2464068C .alpha.-form or .beta.-form crystal of (r)-2-(2-aminothiazol-4yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl)acetanilide
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2414018C 2-aminocarbonyl-9h-purine derivatives
10/16/2007CA2340920C A method for preventing the onset of asthma
10/16/2007CA2336654C Plaster which contains steroids, and a method for the production and use thereof
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2319275C Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
10/16/2007CA2288706C Use of high dose retinoids for the treatment of skin disorders
10/16/2007CA2288024C Compositions comprising condensation polymer of an aromatic sulfonic acid and an aldehyde for preventing pregnancy
10/16/2007CA2281807C Method of treating a tumor
10/16/2007CA2272584C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
10/16/2007CA2256013C Crystal modification of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-4-carboxamide and its use as antiepileptic
10/16/2007CA2248087C Improved vision through photodynamic therapy of the eye
10/16/2007CA2233312C Active oxygen scavengers containing pterin derivatives
10/16/2007CA2214026C Pharmaceutical compositions comprising monoamine oxidase b inhibitors
10/16/2007CA2209229C Novel sulfamate compound containing n-substituted carbamoyl group and method for preparing the same
10/16/2007CA2191478C Process for removing bile salts from a patient and alkylated compositions therefor
10/14/2007CA2582784A1 Methods and products for enhancing energy and nutrition in human beings
10/13/2007CA2584745A1 Use of imidazo(2,1-b) -1,3,4-thiadiazole-2-sulfonamide compounds to treat neuropathic pain
10/13/2007CA2578561A1 Topical composition and process for solubilizing an acid in an organic compound
10/11/2007WO2007115341A2 Transaction management system
10/11/2007WO2007115306A2 Compounds for diseases and disorders
10/11/2007WO2007115305A2 Oral dosage forms including an antiplatelet agent and an acid inhibitor
10/11/2007WO2007115282A2 Use of ketogenic compounds for treatment of age-associated memory impairment
10/11/2007WO2007115278A2 3,6,11-tricyclolide
10/11/2007WO2007115269A2 Orally bioavailable caffeic acid related anticancer drugs
10/11/2007WO2007115261A2 Drug delivery methods, structures, and compositions for nasolacrimal system
10/11/2007WO2007115259A2 Nasolacrimal drainage system implants for drug therapy
10/11/2007WO2007115233A2 System and method for making a compressed earth block
10/11/2007WO2007115232A2 Cxcr4 modulators
10/11/2007WO2007115198A2 Compliant electrical stimulation leads and methods of fabrication
10/11/2007WO2007115187A2 Monetizing service calls through advertising
10/11/2007WO2007115147A2 Thermometer
10/11/2007WO2007115146A2 Protection against charging damage in hybrid orientation transistors
10/11/2007WO2007115143A2 Dead spindle pto with compliant grounding mechanism
10/11/2007WO2007115135A2 Aircraft passenger seat
10/11/2007WO2007115099A2 Apparatus for mixing gasses and liquids
10/11/2007WO2007115098A2 Method and system for providing focused search results
1 ... 3545 3546 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 ... 7860